. Author manuscript; available in PMC: 2017 Nov 1.

Published in final edited form as: Magn Reson Imaging. 2016 Jul 22;34(9):1248–1255. doi: 10.1016/j.mri.2016.07.004

Table 1.

Patient demographics and Pearson’s correlation coefficient (R) with SAGE

Patients: Primary Glioma	Age	Sex	Pathology	Pearson’s correlation (R) with SAGE (tumor ROI)
Patients: Primary Glioma	Age	Sex	Pathology	sSAGE ΔR₂^*	sSAGE ΔR₂	sSAGE T₁-w
1	51	Male	Grade IV glioblastoma	0.97	0.95	0.98
2	55	Male	Grade III oligodendroglioma	0.92	0.88	0.94
3	42	Female	Grade IV glioblastoma	0.96	0.94	0.88
Patients: Metastatic Tumors	Age	Sex	Primary tumor site	Pearson’s correlation (R) with SAGE (tumor ROI)
Patients: Metastatic Tumors	Age	Sex	Primary tumor site	sSAGE ΔR₂^*	sSAGE ΔR₂	sSAGE T₁-w
1	62	Female	Lung - non-small cell	0.97	0.95	0.95
2	57	Male	Lung - non-small cell	0.81	0.87	0.80
3	72	Female	Melanoma	0.94	0.86	0.92
4	52	Female	Unknown	0.98	0.93	0.93
5	47	Male	Melanoma	0.78	0.78	0.75
Mean:				0.92	0.90	0.89